NewLink Genetics Corporation | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (33)

View All

Latest Posts

About This Stock More About This Stock
4 Small Biotech Stocks Likely To Witness More Upside In 2019
Article By: Zacks Investment Research
Saturday, March 30, 2019 5:45 AM EDT
Here are four companies from the biotech/drug sector which have performed well so far in 2019 and still hold upside. All these stocks have seen their share price and earnings estimates rise this year.
In this article: ANIP, KMDA, GHDX, NLNK Also: VRTX, BIIB, AMGN
Read
NewLink Genetics Plunges After Competitor IDO Drug Fails In Trial
Article By: The Fly
Friday, April 6, 2018 1:08 PM EDT
Shares of NewLink Genetics (NLNK), a clinical-stage company focused on cancer, plunged in pre-market trading after a competitor exploring the same areas of cancer treatment reported a clinical trial that did not succeed in achieving its goal.
In this article: MRK, NLNK, NKTR
Read
Newlink Genetics Prices Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Wednesday, October 4, 2017 2:05 PM EDT
NewLink Genetics Corporation, today announced the pricing of its underwritten public offering of 5,000,000 shares of its common stock at a price to the public of $10.25 per share.
In this article: NLNK
Read
Late Slide In Tech Mega-Caps Leaves Averages Mixed For Week
Article By: The Fly
Saturday, June 10, 2017 10:38 AM EDT
Stocks appeared in line for a slight weekly advance until Friday afternoon, when a sharp decline in a number of mega-cap tech stock pushed the Nasdaq down nearly 2.5% at its low point.
In this article: DFT, DHI, DLR, FOR, JWN, M, THO, VZ, CLDR, AMRI, GIII, NLNK, AAPL, AMZN, FRAN, GOOG, MSFT, YHOO, DVAX, JUNO, BABA, META, AMBA, GLYC, KITE, BLUE, MIK, ANTM, PLAY, RDUS, LOXO, DLTH, HDS
Read
Incyte Rises After ASCO Abstracts, But Piper Urges Closer Look
Article By: The Fly
Wednesday, May 17, 2017 9:48 PM EDT
The release of study abstracts for next month's ASCO conference drove significant moves tonight in drugmakers, but Piper Jaffray urged caution on the company's data, saying its "not sure what other investors are seeing that we aren't."
In this article: MRK, INCY, NLNK, AMGN, NKTR, CYTR, BLUE, LBIO, LPTX
Read
All Posts

Latest Tweets for $NLNK

No tweets yet!

PARTNER HEADLINES